MX2007013866A - Composiciones farmaceuticas que comprenden peptidos derivados de la caseina y metodos de uso de los mismos. - Google Patents
Composiciones farmaceuticas que comprenden peptidos derivados de la caseina y metodos de uso de los mismos.Info
- Publication number
- MX2007013866A MX2007013866A MX2007013866A MX2007013866A MX2007013866A MX 2007013866 A MX2007013866 A MX 2007013866A MX 2007013866 A MX2007013866 A MX 2007013866A MX 2007013866 A MX2007013866 A MX 2007013866A MX 2007013866 A MX2007013866 A MX 2007013866A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- pharmaceutical compositions
- casein
- derived peptides
- casein derived
- Prior art date
Links
- 239000005018 casein Substances 0.000 title abstract 3
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 title abstract 3
- 235000021240 caseins Nutrition 0.000 title abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 241001465754 Metazoa Species 0.000 abstract 2
- 244000144972 livestock Species 0.000 abstract 2
- 235000013336 milk Nutrition 0.000 abstract 2
- 239000008267 milk Substances 0.000 abstract 2
- 210000004080 milk Anatomy 0.000 abstract 2
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 239000000693 micelle Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000032696 parturition Effects 0.000 abstract 1
- 239000008174 sterile solution Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Marine Sciences & Fisheries (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Nutrition Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67629205P | 2005-05-02 | 2005-05-02 | |
| US68869705P | 2005-06-09 | 2005-06-09 | |
| PCT/IL2006/000524 WO2006117784A2 (en) | 2005-05-02 | 2006-05-02 | Pharmaceutical compositions comprising casein derived peptides and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2007013866A true MX2007013866A (es) | 2008-04-07 |
Family
ID=37308387
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2007013866A MX2007013866A (es) | 2005-05-02 | 2006-05-02 | Composiciones farmaceuticas que comprenden peptidos derivados de la caseina y metodos de uso de los mismos. |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US7968513B2 (enExample) |
| EP (1) | EP1890720B1 (enExample) |
| JP (1) | JP5247429B2 (enExample) |
| KR (2) | KR20130122979A (enExample) |
| CN (1) | CN106421749A (enExample) |
| AR (1) | AR059462A1 (enExample) |
| AU (1) | AU2006242842B2 (enExample) |
| BR (1) | BRPI0611301A2 (enExample) |
| CA (1) | CA2607155C (enExample) |
| CL (1) | CL2011000039A1 (enExample) |
| EA (1) | EA016039B1 (enExample) |
| ES (1) | ES2400511T3 (enExample) |
| IN (1) | IN2014DN10391A (enExample) |
| MX (1) | MX2007013866A (enExample) |
| NZ (1) | NZ563936A (enExample) |
| PL (1) | PL1890720T3 (enExample) |
| UY (1) | UY29515A1 (enExample) |
| WO (1) | WO2006117784A2 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2400511T3 (es) * | 2005-05-02 | 2013-04-10 | Mileutis Ltd. | Composiciones farmacéuticas que comprenden péptidos derivados de la caseina y métodos para el uso de las mismas |
| JP5507555B2 (ja) * | 2008-06-30 | 2014-05-28 | チョ−エー・ファーム・カンパニー・リミテッド | 豚のαＳ１カゼイン遺伝子、そのプロモーター、及びその用途 |
| US8133916B1 (en) | 2009-03-10 | 2012-03-13 | Amelgo, LLC | Control of milk production and mammary involution |
| US20110017323A1 (en) * | 2009-07-22 | 2011-01-27 | Ewa Herbst | Method and apparatus for inline testing |
| CA2797658C (en) * | 2010-04-21 | 2021-06-08 | Mileutis Ltd. | Casein peptide for use in the treatment of uterine infections |
| FR2971423B1 (fr) * | 2011-02-15 | 2014-01-10 | Ceva Sante Animale | Composition veterinaire antiprolactinique destinee aux ruminants |
| ES2759980T3 (es) | 2012-03-19 | 2020-05-12 | Mileutis Ltd | Péptidos para el manejo de la lactación |
| EP2810695A1 (en) * | 2013-06-06 | 2014-12-10 | Ceva Sante Animale | Compositions and Method for controlling infections in non-human mammals using acute phase proteins |
| AU2017358060B2 (en) * | 2016-11-09 | 2023-05-04 | Charles Sturt University | Livestock supplement and use thereof |
| CN110267550B (zh) * | 2016-12-13 | 2022-08-30 | 帝斯曼知识产权资产管理有限公司 | 多不饱和脂肪酸盐制剂(i) |
| CN108017709B (zh) * | 2017-12-12 | 2020-04-10 | 浙江辉肽生命健康科技有限公司 | 一种生物活性多肽kepmigvnqela及其制备方法和应用 |
| MX2022010250A (es) * | 2020-02-19 | 2022-11-09 | Perfect Day Inc | Proteínas recombinantes hipoalergénicas de leche y composiciones que comprenden las mismas. |
| EP4619011A1 (en) * | 2022-11-17 | 2025-09-24 | Mileutis Ltd. | Compositions and methods for modulating mammary disorders and conditions |
| AU2024274533A1 (en) * | 2023-05-16 | 2025-12-04 | Mileutis Ltd. | Enhanced milk quality |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3764670A (en) * | 1970-10-28 | 1973-10-09 | Ministry Of Agriculture | Polypeptidic anti-biotic substances derived from casein |
| FR2474829B1 (fr) * | 1980-02-01 | 1983-09-09 | Agronomique Inst Nat Rech | Procede de traitement d'une matiere a base de caseine contenant des phosphocaseinates de cations monovalents ou leurs derives, produits obtenus et applications |
| US5405756A (en) * | 1982-03-30 | 1995-04-11 | Meiji Seika Kaisha, Ltd. | Transparent acid drink containing acid-soluble casein phosphopeptide |
| US5015628A (en) * | 1986-06-12 | 1991-05-14 | The University Of Melbourne | Anticariogenic phosphopeptides |
| ES2149771T3 (es) * | 1991-04-19 | 2000-11-16 | Univ Melbourne | Produccion de fosfopeptidos a partir de la caseina. |
| US5227154A (en) * | 1991-08-22 | 1993-07-13 | The University Of Melbourne | Phosphopeptides for the treatment of dental calculus |
| KR0140248B1 (ko) * | 1995-03-23 | 1998-06-15 | 한상기 | 신규한 카제인 포스포펩티드, 그것을 포함하는 카제인 및 그 제조방법 |
| AUPO566297A0 (en) * | 1997-03-13 | 1997-04-10 | University Of Melbourne, The | Calcium phosphopeptide complexes |
| AUPP494798A0 (en) * | 1998-07-29 | 1998-08-20 | Pacific Biolink Pty Limited | Protective protein formulation |
| AU775999B2 (en) | 1999-08-24 | 2004-08-19 | Meiji Seika Pharma Co., Ltd. | Growth promoting compositions for mammals and method of promoting the growth of mammals by using the same |
| US6391849B1 (en) * | 1999-11-19 | 2002-05-21 | Agricultural Research Organization, The Volcani Center | Method and pharmaceutical composition for disrupting lactation in a mammary gland and for treating and preventing mastitis |
| US7666996B2 (en) * | 2000-03-01 | 2010-02-23 | Peptera Pharmaceuticals Ltd | Casein derived peptides and uses thereof |
| IL134830A0 (en) * | 2000-03-01 | 2001-05-20 | Chay 13 Medical Res Group N V | Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them |
| CN1496368A (zh) * | 2001-03-09 | 2004-05-12 | 明治制果株式会社 | 免疫增强剂 |
| BRPI0507822A (pt) | 2004-03-01 | 2007-07-10 | Peptera Pharmaceuticals Ltd | método e composição farmacêutica para a prevenção ou o tratamento de uma doença ou uma condição autoimune ou infecciosa, método e composição farmacêutica para a prevenção ou o tratamento de uma doença ou uma condição do sangue, método e composição farmacêutica para modular a formação de células do sangue, método e composição farmacêutica para intensificar a mobilização periférico da célula tronco, método e composição farmacêutica para a prevenção ou o tratamento de uma doença ou uma condição metabólica, método e composição farmacêutica para a prevenção ou o tratamento das condições associadas com doses mieloablativas de quimioradioterapia suportadas pelo transplante autólogo de medula óssea ou de células tronco do sangue periférico (asct) ou pelo transplante alogenéico de medula óssea (bmt), método e composição farmacêutica para aumentar o efeito de um fator estimulante de células do sangue, método e composição farmacêutica para intensificar a colonização de células tronco do sangue doadas em um receptor mieloablatado, método e composição farmacêutica para a prevenção ou o tratamento de uma doença ou uma condição bacteriana, composição farmacêutica para o tratamento ou a prevenção de uma indicação selecionada do grupo que consiste em doença ou condição autoimune, doença viral, infecção viral, doença hematológica, deficiências hematológicas, trombocitopenia, pancitopenia, granulopenia, hiperlipidemia, hipercolesterolemia, glucosuria, hiperglicemia, diabetes, aids, hiv-1, distúrbios de células t auxiliares, deficiências de células dendrìticas, deficiências de macrofagos, distúrbios de células tronco hematopoiéticas incluindo distúrbios com plaquetas, linfócitos, células do plasma e neutrófilos, condições pré-leucêmicas, condições leucêmicas, distúrbios do sistema imunológico resultantes da terapia de quimioterapia ou de radiação, distúrbios do sistema imunológico humano resultantes do tratamento das doenças de deficiência imunológica e infecções bacterianas, composição farmacêutica para o tratamento ou a prevenção de um indicação selecionada do grupo que consiste em doença hematológica, deficiências hematológicas, trombocitopenia, pancitopenia, granulopenia, deficiências de células dendrìticas, deficiências de macrofagos, distúrbios de células tronco hematopoiéticas incluindo distúrbios com plaquetas, linfócitos, células do plasma e neutrófilos, condições pré-leucêmicas, condições leucêmicas, sìndrome mielodisplástiacas, malignidades não mielóides, anemia plástica e insuficiência da medula óssea, peptìdeo purificado, peptìdeo quimérico purificado, peptìdeo quimérico, composição farmacêutica, composição farmacêutica para a prevenção ou o tratamento de uma condição associada com um agente infeccioso de sars, método de processamento a baixa temperatura de hidrolisato proteolìtico de caseìna e hidrolisato de proteìna de caseìna |
| ES2400511T3 (es) * | 2005-05-02 | 2013-04-10 | Mileutis Ltd. | Composiciones farmacéuticas que comprenden péptidos derivados de la caseina y métodos para el uso de las mismas |
-
2006
- 2006-05-02 ES ES06728320T patent/ES2400511T3/es active Active
- 2006-05-02 JP JP2008509574A patent/JP5247429B2/ja active Active
- 2006-05-02 BR BRPI0611301-0A patent/BRPI0611301A2/pt not_active Application Discontinuation
- 2006-05-02 NZ NZ563936A patent/NZ563936A/en unknown
- 2006-05-02 PL PL06728320T patent/PL1890720T3/pl unknown
- 2006-05-02 WO PCT/IL2006/000524 patent/WO2006117784A2/en not_active Ceased
- 2006-05-02 CA CA2607155A patent/CA2607155C/en active Active
- 2006-05-02 AU AU2006242842A patent/AU2006242842B2/en active Active
- 2006-05-02 MX MX2007013866A patent/MX2007013866A/es active IP Right Grant
- 2006-05-02 IN IN10391DEN2014 patent/IN2014DN10391A/en unknown
- 2006-05-02 EA EA200702401A patent/EA016039B1/ru not_active IP Right Cessation
- 2006-05-02 CN CN201610544021.9A patent/CN106421749A/zh active Pending
- 2006-05-02 UY UY29515A patent/UY29515A1/es not_active Application Discontinuation
- 2006-05-02 KR KR1020137025206A patent/KR20130122979A/ko not_active Ceased
- 2006-05-02 US US11/913,239 patent/US7968513B2/en active Active
- 2006-05-02 EP EP06728320A patent/EP1890720B1/en active Active
- 2006-05-15 AR ARP060101766A patent/AR059462A1/es not_active Application Discontinuation
-
2007
- 2007-12-03 KR KR1020077028185A patent/KR101340676B1/ko active Active
-
2011
- 2011-01-07 CL CL2011000039A patent/CL2011000039A1/es unknown
- 2011-05-13 US US13/107,331 patent/US8338363B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CL2011000039A1 (es) | 2011-06-10 |
| KR101340676B1 (ko) | 2013-12-18 |
| EP1890720B1 (en) | 2013-01-09 |
| AU2006242842B2 (en) | 2011-12-08 |
| KR20080012933A (ko) | 2008-02-12 |
| CA2607155C (en) | 2016-09-13 |
| PL1890720T3 (pl) | 2013-06-28 |
| US20110212886A1 (en) | 2011-09-01 |
| WO2006117784A2 (en) | 2006-11-09 |
| NZ563936A (en) | 2010-03-26 |
| JP5247429B2 (ja) | 2013-07-24 |
| IN2014DN10391A (enExample) | 2015-08-14 |
| AR059462A1 (es) | 2008-04-09 |
| EP1890720A2 (en) | 2008-02-27 |
| AU2006242842A1 (en) | 2006-11-09 |
| EP1890720A4 (en) | 2010-05-26 |
| ES2400511T3 (es) | 2013-04-10 |
| KR20130122979A (ko) | 2013-11-11 |
| US7968513B2 (en) | 2011-06-28 |
| US8338363B2 (en) | 2012-12-25 |
| CA2607155A1 (en) | 2006-11-09 |
| EA016039B1 (ru) | 2012-01-30 |
| WO2006117784A3 (en) | 2009-05-22 |
| JP2008540399A (ja) | 2008-11-20 |
| EA200702401A1 (ru) | 2008-08-29 |
| US20090069218A1 (en) | 2009-03-12 |
| BRPI0611301A2 (pt) | 2010-08-31 |
| CN106421749A (zh) | 2017-02-22 |
| UY29515A1 (es) | 2007-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2007013866A (es) | Composiciones farmaceuticas que comprenden peptidos derivados de la caseina y metodos de uso de los mismos. | |
| CN102550481A (zh) | 白山羊羔羊的饲养方法 | |
| EP2046943A4 (en) | MUTTERMILK ISOLATED MILKY ACID BACTERIA WITH PROBIOTIC ACTIVITY AND HEMMETICITY AGAINST BODY WEAKNESS INCREASE | |
| AR063304A1 (es) | Nueva composicion para mejorar la calidad de la piel y proceso para preparar la misma | |
| NZ594710A (en) | System and method for cleaning teats of a milk-producing animal utilising a hand-held applicator with scrubbing elements which disperses chlorine dioxide | |
| WO2005062878A3 (en) | Canine probiotic bifidobacteria globosum | |
| MX2013002949A (es) | Composiciones de acido abscisico para salud animal. | |
| FR3056107B1 (fr) | Utilisations de pidolate de calcium et/ou de magnesium. | |
| RU2013153088A (ru) | Композиции, усиливающие вкусовую привлекательность | |
| ZA201008588B (en) | Process for producing acidulated 50% concentrated solution and dry powder of peptides from protein products and waste of animal, fish and aquaculture origin | |
| EA201270220A1 (ru) | Молочная композиция, ее применение и продукты на ее основе, смесь для кормления млекопитающих и способ получения такой молочной композиции | |
| PL2219437T5 (pl) | Urządzenie do przetrzymywania zwierząt mlecznych | |
| Kumar et al. | Existing calf rearing and milking management practices followed by dairy farmers in Uttarakhand | |
| ATE476104T1 (de) | Verwendung von 25-hydroxy-vitamin d3 zur verbesserung der vitalität von tieren | |
| RU2009101018A (ru) | Индукция толерантности к белкам яиц | |
| BR112015015611A2 (pt) | composições de iga secretora, métodos para a sua preparação e métodos para a sua utilização | |
| WO2011012240A3 (de) | Lipopeptide zur therapie und prophylaxe allergischer erkrankungen | |
| NZ590609A (en) | The use of sandalwood extracts and analogues as animal food additives | |
| MY169478A (en) | Nutritional composition for infants delivered via caesarean section | |
| WO2020176055A3 (en) | Measurement method of body composition in ruminant class animals | |
| RU2006114596A (ru) | Кормовая добавка для поросят-гипотрофиков с использованием стевии | |
| NO20070661L (no) | Anvendelsen av medisinske planter og ekstrakter derav for dyrs velvaere i veterinaer medisin og zooteknikk | |
| Sarma et al. | Trans vaginal correction of dystocia due to fetal arthrogryposis in a Holstein Friesian cow | |
| WO2002061066A8 (en) | Method for producing an enzyme from a novel source | |
| Frondelius et al. | Effect of cow factors and daily walking distance on commonly used lameness indicators |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |